The scant PDX tumor cells remaining in B7H3.CAR EBVST-treated mice retained high expression of B7-H3, supporting that there was no antigen escape arising from CAR T-cell therapy (Fig. 4G). This evidence concerns the gene CD276 and neoplasm.